{{Rsnum
|rsid=4833079
|Gene=NHLRC4
|Chromosome=4
|position=38653060
|Orientation=plus
|GMAF=0.1947
|Gene_s=NHLRC4
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 15.9 | 50.4 | 33.6
| HCB | 0.0 | 0.7 | 99.3
| JPT | 0.0 | 4.4 | 95.6
| YRI | 2.0 | 18.4 | 79.6
| ASW | 1.8 | 22.8 | 75.4
| CHB | 0.0 | 0.7 | 99.3
| CHD | 0.0 | 3.7 | 96.3
| GIH | 2.0 | 15.8 | 82.2
| LWK | 0.0 | 15.5 | 84.5
| MEX | 0.0 | 24.1 | 75.9
| MKK | 0.0 | 17.3 | 82.7
| TSI | 10.8 | 40.2 | 49.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22703024
|Title=Toll-like receptor gene polymorphisms confer susceptibility to graft-versus-host disease in allogenic hematopoietic stem cell transplantation
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}